2020-present:      AlstonBrantley

2020-present:      Managing Director

                          AlstonBrantley (Princeton, NJ, USA)

• invests in and provides governance and advice to emerging bioscience and fintech companies

​

2003-2019:        Johnson & Johnson Consumer Healthcare

2017-2019:        Chief Operating Officer

                          Johnson & Johnson Consumer Healthcare (Skillman, NJ and New Brunswick, NJ, USA)

• operationally responsible for new products development, registration, launch and lifecycle management world-wide at J&J’s Consumer Healthcare (~$14 BN NTS)

• transformed large organization without hurting innovative output by right-sizing, relocated activities to Poland and India, reducing spans & layers, and cut lower-value overhead

 

2012-2017:        Global Head of R&D

                          Johnson & Johnson OTC Pharmaceuticals (Skillman, NJ and Fort Washington, PA, USA)

• globally responsible for product design and development, pipeline creation and other R&D accountabilities of J&J’s OTC drugs business (~$4.5 BN NTS in 2017)

• rebuilt R&D and pipeline after 2010 manufacturing quality recalls and Consent Decree in US: J&J OTC now grows fastest of all large OTC companies and consistently gains market share

 

2006-2012:        Global Head of Global Markets R&D, Technology and Regulatory Affairs

                          Johnson & Johnson Consumer Research & Development (Skillman, NJ, USA)

• responsible for R&D in Europe, AsiaPacific and Latin America, and globally for Pharmacovigilance, Regulatory, Medical and R&D Operations across all product categories

• member of J&J Consumer’s Group Operating Committee (2011-2012)

• transformed multi-region R&D organization into globally synchronized/leveraged one

 

2007-2009:        Chief Compliance Officer

                          Johnson & Johnson Consumer Companies (New Brunswick, NJ, USA)

• leading HealthCare Compliance, Government Contracting Compliance, Privacy and Foreign Corrupt Practices Act management across all J&J Consumer companies

• built these new (for J&J Consumer) legally required capabilities from scratch

 

2003-2006:        Global Head of R&D Operations & Wound Care R&D

                          Johnson & Johnson Consumer Research & Development (Skillman, NJ, USA)

• globally responsible for R&D Operations (analytical, micro, clinical trials, etc.) and (from ’05) leading R&D for Wound Care (~$1 BN NTS in ‘06) and Ophthalmology Rx

• established new R&D labs in Shanghai and Mumbai with Emerging Markets focus

 

1984-2003:        Janssen Pharmaceuticals

2002-2003:        Senior Vice President, Project and Portfolio Management

                          Johnson & Johnson Pharmaceutical Research & Development (Titusville, NJ, USA)

• responsible for all project management; built portfolio management as new capability

 

1999-2002:        Senior Vice President, Global Clinical Operations

                          Johnson & Johnson Pharmaceutical Research & Development (Titusville, NJ, USA) (2000-2002)

                          Janssen Research Foundation (Beerse, Belgium) (1999-2000)

• globally responsible for clinical trials, data management, statistics, etc. for J&J Pharma

• installed new drug development process and governance at R&D and Strategic Marketing while leading all drug development teams (2001-2002)

• integrated ClinOps across all J&J pharma R&D groups when Janssen and RWJ R&D merged

 

1991-1999:        Vice President, Coordination & Information Management

                          Janssen Research Foundation (Beerse, Belgium)

• leading R&D planning, IT, finance, project management and licensing (through 1995); established (from 1996) and led functional genomics, molecular biology, high-throughput screening, bioinformatics and pharmacogenomics, attracting international talent

• opened Janssen to biotech collaborations: identified and negotiated 4 deals (1994-1995)

 

1984-1990:        Research Scientist

                          Janssen Research Foundation (Beerse, Belgium)

• performing bench research (1984-1985) and research management (1985-1990)

 

1987-1998:        Janssen Biotech

1987-1998:        Founder and General Manager

                          Janssen Biotech (Olen, Belgium)

• founded Janssen Biotech N.V. around research reagents (1988: $2MM sales); negotiated 10-year tax holiday with Belgian government; sold reagents business to Amersham and used proceeds to build drug delivery systems company with own FDA-approved plant (1998: $263MM sales)

 

1980-1983:        Belgian National Fund for Scientific Research

1980-1983:        Researcher

                          National Fund for Scientific Research (Antwerp, Belgium)

• investigating molecular mechanism of exocytosis in neurotransmission

 

Education

1984:                Ph.D., Biochemical Pharmacology, University of Antwerp (Belgium) - summa cum laude

1980:                M.S., Biochemistry, University of Antwerp (Belgium) - magna cum laude

1978:                B.S., Chemistry, University of Limburg (Belgium) - magna cum laude